An international study involving 13 countries demonstrated that Immunoscore, which quantifies the density of CD8+ and CD3+ cells in tumour core versus invasive margin based on immunohistochemistry images, was a reproducible and robust prognostic factor in patients with stage I–III colon cancer [22]. Here, CD8A is linked to neoplasm.